REDCO HEALTHY (02370) announced its unaudited interim results for the six months ended June 30, 2025. The company reported revenue of RMB 209 million, representing a decrease of 1.47% compared to the same period last year. Shareholders' attributable loss reached RMB 5.742 million, compared to a shareholders' attributable profit of RMB 1.073 million in the corresponding period of the previous year, marking a shift from profit to loss year-over-year. Basic loss per share was 2.87 cents.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments